Total Payments
$7,216
2024 Payments
$1,979
Companies
29
Transactions
359
Medicare Patients
7,609
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$7,216 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,216 | 359 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,557 | 90 | $0 (2024) |
| Janssen Biotech, Inc. | $1,213 | 53 | $0 (2024) |
| Lilly USA, LLC | $587.79 | 29 | $0 (2024) |
| Incyte Corporation | $581.00 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $473.14 | 18 | $0 (2024) |
| GENZYME CORPORATION | $409.41 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $347.60 | 18 | $0 (2024) |
| Celgene Corporation | $327.59 | 20 | $0 (2019) |
| Amgen Inc. | $302.35 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $190.21 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,979 | 84 | ABBVIE INC. ($392.51) |
| 2023 | $1,330 | 57 | Janssen Biotech, Inc. ($367.03) |
| 2022 | $670.56 | 31 | Janssen Biotech, Inc. ($220.20) |
| 2021 | $126.07 | 2 | Allergan, Inc. ($111.58) |
| 2020 | $224.92 | 11 | Lilly USA, LLC ($47.19) |
| 2019 | $998.33 | 58 | AbbVie, Inc. ($183.97) |
| 2018 | $851.89 | 56 | AbbVie, Inc. ($336.64) |
| 2017 | $1,036 | 60 | AbbVie, Inc. ($151.10) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.93 | General |
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.57 | General |
| Category: Immunology | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $36.94 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.66 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $39.40 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.64 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 1,828 | 2,454 | $1.2M | $614,164 |
| 2022 | 35 | 1,874 | 2,645 | $1.2M | $635,565 |
| 2021 | 33 | 1,962 | 2,893 | $1.4M | $717,551 |
| 2020 | 35 | 1,945 | 2,547 | $1.4M | $717,388 |
Total Patients
7,609
Total Services
10,539
Medicare Billing
$2.7M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 412 | 525 | $450,200 | $220,672 | 49.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 113 | 132 | $106,180 | $56,619 | 53.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 107 | 165 | $85,851 | $52,851 | 61.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 182 | 206 | $79,239 | $36,357 | 45.9% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 49 | 53 | $61,669 | $36,292 | 58.8% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 47 | 47 | $59,246 | $35,963 | 60.7% |
| Q4186 | Epifix, per square centimeter | Office | 2023 | 21 | 242 | $47,349 | $28,555 | 60.3% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 42 | 44 | $42,222 | $25,631 | 60.7% |
| 14021 | Repair of wound of scalp, arms, or legs by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 32 | 34 | $37,152 | $22,565 | 60.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 134 | 145 | $58,081 | $17,890 | 30.8% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2023 | 16 | 17 | $23,286 | $13,901 | 59.7% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 25 | 25 | $24,306 | $13,815 | 56.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 75 | 101 | $12,951 | $6,611 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 79 | $9,085 | $5,157 | 56.8% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 32 | 32 | $12,562 | $5,135 | 40.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 43 | 45 | $13,931 | $4,482 | 32.2% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 16 | 17 | $7,194 | $3,743 | 52.0% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 26 | 26 | $9,351 | $3,630 | 38.8% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 45 | 46 | $9,991 | $3,077 | 30.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 68 | 83 | $7,037 | $2,528 | 35.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 25 | 61 | $3,883 | $2,390 | 61.6% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 29 | 30 | $3,872 | $2,384 | 61.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 20 | $4,528 | $2,228 | 49.2% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 12 | 12 | $4,006 | $2,092 | 52.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 30 | 32 | $4,590 | $2,090 | 45.5% |
About Dr. Mandy Harting, MD
Dr. Mandy Harting, MD is a MOHS-Micrographic Surgery healthcare provider based in The Woodlands, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1437324480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mandy Harting, MD has received a total of $7,216 in payments from pharmaceutical and medical device companies, with $1,979 received in 2024. These payments were reported across 359 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,216).
As a Medicare-enrolled provider, Harting has provided services to 7,609 Medicare beneficiaries, totaling 10,539 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology, Dermatology
- Location The Woodlands, TX
- Active Since 04/29/2008
- Last Updated 09/26/2013
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1437324480
Products in Payments
- TREMFYA (Drug) $817.65
- DUPIXENT (Biological) $679.78
- Humira (Biological) $612.63
- TALTZ (Drug) $587.79
- OPZELURA (Drug) $581.00
- SKYRIZI (Biological) $403.44
- RINVOQ (Biological) $379.79
- COSENTYX (Biological) $234.10
- REMICADE (Biological) $205.02
- Tremfya (Drug) $159.91
- Enbrel (Biological) $154.87
- DUPIXENT (Drug) $135.81
- Otezla (Drug) $116.63
- ILUMYA (Biological) $95.39
- ENSTILAR (Drug) $89.12
- SOOLANTRA (Drug) $88.59
- Cimzia (Drug) $81.63
- ONEXTON (Drug) $76.31
- DUPIXENT DUPILUMAB INJECTION (Biological) $66.96
- Bimzelx (Biological) $66.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.